StockData
Fresenius Medical Care AG logo

Fresenius Medical Care AG (FMCQF) stock

FMCQFOTCServices-Misc Health & Allied Services, NECAlso trades as FMS
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 0/30
$43.82−0.00 (-0.00%)

Close on Oct 19, 2026Market cap $12.24BP/E –Yield –

Fresenius Medical Care r&d expenses

Research and development expenses are spending on new products and technology.

Fresenius Medical Care's R&D Expenses for the twelve months ending Dec 31, 2016 was $162.36M. For fiscal 2016 it was $162.36M, up 15.7% from the year before. The highest annual figure on record is $162.36M in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2016Dec 31, 2016$162.36M+15.7%
FY2015Dec 31, 2015$140.30M+14.9%
FY2014Dec 31, 2014$122.11M-2.9%
FY2013Dec 31, 2013$125.81M+12.7%
FY2012Dec 31, 2012$111.63M+0.7%
FY2011Dec 31, 2011$110.83M+14.8%
FY2010Dec 31, 2010$96.53M+2.9%
FY2009Dec 31, 2009$93.81M+16.9%
FY2008Dec 31, 2008$80.24M+20.6%
FY2007Dec 31, 2007$66.52M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2016Dec 31, 2016$42.23M–
Q3 FY2016Sep 30, 2016$43.90M–

More Fresenius Medical Care figures

See a number that looks wrong?